NIH VideoCast - FDA NIH WHO Public Workshop - Pandemic Vaccine Development (Day 1)

Skip Navigation

FDA NIH WHO Public Workshop - Pandemic Vaccine Development (Day 1)

Loading... Loading video...

Air date:	Monday, December 10, 2007, 8:30:00 AM Time displayed is Eastern Time, Washington DC Local
Views:	Total views: 125 * This only includes stats from October 2011 and forward.
Category:	Conferences
Runtime:	06:24:06
Closed captioning:	Check box to display CC outside of the video Note: You can drag the captioning window around and resize it
Description:	FDA/NIH/WHO Public Workshop - Immune Correlates of Protection Against Influenza A Viruses in Support of Pandemic Vaccine Development FDA's Center for Biologics Evaluation and Research, in cooperation with the National Institutes of Health's Division of Intramural Research within the National Institute of Allergy and Infectious Diseases and the World Health Organization, is convening this public workshop. The public workshop will include discussions on: (1) Current knowledge regarding correlates of protection against seasonal influenza, (2) immune responses to avian influenza infections and vaccines for novel influenza viruses in humans, (3) assays to evaluate vaccine immunogenicity, and (4) evaluation of avian influenza vaccine efficacy. The goals of the public workshop are to: (1) Identify the gaps in our knowledge and abilities in addressing the unique challenges encountered in the development and evaluation of vaccines intended to protect against pandemic influenza, and (2) facilitate implementation of a global research agenda to improve efficacy assessment of pandemic influenza vaccines. Additional information, including the draft agenda can be found at http://www.fda.gov/cber/meetings/panflu121007.htm

NLM Title:	FDA NIH WHO public workshop--pandemic vaccine development / FDA, NIH, and WHO.
Author:	United States. Food and Drug Administration.
Publisher:
Abstract:	(CIT): FDA/NIH/WHO Public Workshop - Immune Correlates of Protection Against Influenza A Viruses in Support of Pandemic Vaccine Development. FDA's Center for Biologics Evaluation and Research, in cooperation with the National Institutes of Health's Division of Intramural Research within the National Institute of Allergy and Infectious Diseases and the World Health Organization, is convening this public workshop. The public workshop will include discussions on: (1) Current knowledge regarding correlates of protection against seasonal influenza, (2) immune responses to avian influenza infections and vaccines for novel influenza viruses in humans, (3) assays to evaluate vaccine immunogenicity, and (4) evaluation of avian influenza vaccine efficacy. The goals of the public workshop are to: (1) Identify the gaps in our knowledge and abilities in addressing the unique challenges encountered in the development and evaluation of vaccines intended to protect against pandemic influenza, and (2) facilitate implementation of a global research agenda to improve efficacy assessment of pandemic influenza vaccines. Additional information, including the draft agenda can be found at http://www.fda.gov/cber/meetings/panflu121007.htm.
Subjects:	Disease Outbreaks--prevention & control Immunogenetics Influenza A virus Influenza Vaccines Influenza, Human--prevention & control
Publication Types:	Congress Webcast
NLM Classification:	WC 515
NLM ID:	101463211
CIT Live ID:	6418
Permanent link:	https://videocast.nih.gov/watch=6418

Related Videos...